Skip to main content
Signal8

Tokman Alexander Y

SEC insider (Form 3/4/5 filer). CIK 0001334483. Chief Executive Officer at ENDRA Life Sciences Inc. (NDRA). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in ANN ARBOR, MI.

Companies Tokman Alexander Y has filed insider reports for

  • ENDRA Life Sciences Inc. (NDRA): Director, Officer, Chief Executive Officer
Tokman Alexander Y profile photo

Tokman Alexander Y

CIK: 0001334483

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ENDRA Life Sciences Inc. logo
NDRA

ENDRA Life Sciences Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ENDRA Life Sciences Inc. logo
    NDRA

    ENDRA Life Sciences Inc.

    Mar 2, 2026
    Award
    Direct
    26.9K shares-
  • ENDRA Life Sciences Inc. logo
    NDRA

    ENDRA Life Sciences Inc.

    Jan 21, 2026
    Award
    Direct
    75K shares-

1-2 of 2